Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
21 Maio 2024 - 5:05PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Schedule
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary Proxy Statement |
|
|
☐ |
Confidential, for Use of the Commission Only (as
permitted by Rule 14a-6(e)(2)) |
|
|
☐ |
Definitive Proxy Statement |
|
|
☒ |
Definitive Additional Materials |
|
|
☐ |
Soliciting Material under § 240.14a-12 |
IMMIX BIOPHARMA, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment
of Filing Fee (Check all boxes that apply):
☒ |
No fee required |
|
|
☐ |
Fee paid previously with
preliminary materials. |
|
|
☐ |
Fee computed on table in
exhibit required by Item 25(b) per Exchange Act Rules 14a- 6(i)(1) and 0-11 |
![](https://www.sec.gov/Archives/edgar/data/1873835/000149315224020875/formdefa14a_001.jpg)
![](https://www.sec.gov/Archives/edgar/data/1873835/000149315224020875/formdefa14a_002.jpg)
Immix Biopharma (NASDAQ:IMMX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Immix Biopharma (NASDAQ:IMMX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024